Search results

Selected filters:

Analysis
Valuation

Article type

Topic

Sector

Regions

Year

564 results found for your search

Sort options
21 January 2020

Four trends that will shape life sciences IP deal-making in 2020

After a record-breaking 2019, here are the key value-creation issues to look out for in the new decade

14 January 2020

Conversant case illustrates gauntlet facing SEP plaintiffs in China

The Chinese IP office knocked out several claims from the sole patent owned by the NPE that was deemed essential and infringed in a recent Nanjing FRAND ruling

09 January 2020

NPE’s litigation move may be a sign of things to come in the healthcare sector

Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases

17 December 2019

US NPE leverages China litigation to secure Xiaomi deal

Acacia sub-licensor scored a global deal with smartphone maker as key rights neared expiration

12 December 2019

Seoul Semiconductor patent auction analysis reveals a mixed bag of assets

In sales due to be held this month and next, the Korean company offers two radically different portfolios. But value is in the eye of the beholder - and a range of businesses could be making bids

10 December 2019

How the threat of unsold rights, the rise of the in-house dealmaker and a revolution in analytics are re-shaping the IP deals market

As IAM releases this year's brokered patent market survey one of its authors digs deep into the current climate for transactions and explains why some of the grunt work of five years ago is a thing of the past

06 December 2019

Chinese memory upstart secures DRAM patents in hybrid deal with WiLAN

CXMT picks up former Qimonda rights at a time when Beijing government is prioritising creation of national champions

02 December 2019

Panasonic sells semiconductor unit in $250m deal

Acquirer out of Taiwan says transaction will broaden its IP portfolio and add significant R&D resources, but it is not clear just how many patents will change hands

28 November 2019

Apple’s IP chief takes top place in this year’s <em>IAM</em> Market Makers list

Jeff Myers heads the 40-strong selection of the global dealmaking elite thanks in no small part to the iPhone giant’s huge Intel patent play in the summer

28 November 2019

Four IP takeaways from Novartis’ $9.7 billion acquisition of The Medicines Company

Over the weekend, Novartis struck one of the largest deals in the biopharma sectors this year, agreeing to pay $9.7 billion for cardiovascular specialist The Medicines Company

27 November 2019

Leaders at Philips, Lenovo, Broadcom and AT&T named as members of the global IP dealmaking elite

Today we move in the top half of this year’s Market Makers listing and individuals working inside operating companies dominate

26 November 2019

Korean company plans to auction 5G, LED rights

Seoul Semiconductor is kicking off a “new patent management strategy” with two portfolios going under the hammer later this year

26 November 2019

Meet the innovators who drive global IP dealmaking

Part two of this year’s IAM Market Makers countdown covers the individuals sitting in places 30 to 21

25 November 2019

The people who make the world’s IP deals weather revealed

We begin the rundown of the individuals in this year’s IAM Market Makers by naming those who feature in places 40 to 31

19 November 2019

Second listing sees Alibaba on firmer IP footing

The e-commerce giant prices its Hong Kong offering this week. Five years after its NYSE debut, it has a more formidable patent portfolio and new IP-based alliances